ppi-0903 and Brain-Diseases

ppi-0903 has been researched along with Brain-Diseases* in 1 studies

Other Studies

1 other study(ies) available for ppi-0903 and Brain-Diseases

Article	Year
Ceftaroline-associated Encephalopathy in Patients With Severe Renal Impairment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 04-15, Volume: 70, Issue:9 Encephalopathy complicates beta-lactam therapy, particularly with impaired renal function, though no studies have reported ceftaroline-associated encephalopathy. Among 28 patients with estimated glomerular filtration rates <30 mL/min who received ≥5 days of ceftaroline, 3 developed encephalopathy. Ceftaroline, when dosed supra-therapeutically for serious infections, may be a cause of antibiotic-associated encephalopathy. Topics: Anti-Bacterial Agents; Brain Diseases; Ceftaroline; Cephalosporins; Humans; Renal Insufficiency	2020

Article

Year

Ceftaroline-associated Encephalopathy in Patients With Severe Renal Impairment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 04-15, Volume: 70, Issue:9

Encephalopathy complicates beta-lactam therapy, particularly with impaired renal function, though no studies have reported ceftaroline-associated encephalopathy. Among 28 patients with estimated glomerular filtration rates <30 mL/min who received ≥5 days of ceftaroline, 3 developed encephalopathy. Ceftaroline, when dosed supra-therapeutically for serious infections, may be a cause of antibiotic-associated encephalopathy.

Topics: Anti-Bacterial Agents; Brain Diseases; Ceftaroline; Cephalosporins; Humans; Renal Insufficiency

2020